Vimarsana
Biggest News Aggregation in the World

Page 7 - Accessed March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed March Today - Breaking & Trending Today

Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma -April 05, 2024 at 11:31 pm EDT - Vimarsana News

Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma -April 05, 2024 at 11:31 pm EDT

New indication for this one-time infusion may provide patients with a treatment-free respite as early as first relapse ...

Best CD rates today: Boost your savings with today's top APYs on terms of 9+ months — April 5, 2024 - Vimarsana News

Best CD rates today: Boost your savings with today's top APYs on terms of 9+ months — April 5, 2024

Lock in today's best rates in decades on certificates of deposits on a range of CD terms — from 6 months to 5 years.

Source: aol.com
Riding the CFO Roundabout: Securing Hospitality's Financial Leadership Future - Vimarsana News

Riding the CFO Roundabout: Securing Hospitality's Financial Leadership Future

CFOs are on the move. Since 2022, the hospitality sector has witnessed a dramatic shift in its financial leadership environment. Data shows that during the first six months of 2023, 103 CFO (Chief Financial Officer) changes occurred in Fortune 1000 companies.[1] This number represents a 30% increase from the 79 changes in the same period in 2022. From a hospitality perspective, this CFO “carousel” and the high demand in 2023 for CFOs and other finance executives is unlike anything the industry has ever experienced. The demand for top talent has risen across all disciplines, but 2023 was de...

Is 2024 the Year for Psychedelic Medicine? - Vimarsana News

Is 2024 the Year for Psychedelic Medicine?

MDMA-assisted therapy and psilocybin currently lead the way with potential approvals by the FDA.

FDA Approves Iloperidone (Fanapt) for Acute Treatment of Bipolar I Disorder - Vimarsana News

FDA Approves Iloperidone (Fanapt) for Acute Treatment of Bipolar I Disorder

The FDA approved iloperidone for acute treatment of bipolar I disorder on April 02, 2024, according to Vanda Pharmaceuticals.